Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 11 | $235,406 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
05 Mar 2024 16:09 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 04 Mar 2024 | Sale | 1,217 | 16.01 | 19,484 | D |
05 Mar 2024 16:09 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 01 Mar 2024 | Sale | 2,107 | 16.0269 | 33,769 | D |
05 Mar 2024 16:08 | NVCR | NovoCure Ltd | LEONARD FRANK X | EVP, Pres., Novocure Oncology | 04 Mar 2024 | Sale | 840 | 16.01 | 13,448 | D |
05 Mar 2024 16:08 | NVCR | NovoCure Ltd | LEONARD FRANK X | EVP, Pres., Novocure Oncology | 01 Mar 2024 | Sale | 1,679 | 16.0269 | 26,909 | D |
29 Feb 2024 16:38 | NVCR | NovoCure Ltd | LEONARD FRANK X | EVP, Pres., Novocure Oncology | 28 Feb 2024 | Sale | 2,078 | 16.1428 | 33,545 | D |
29 Feb 2024 16:28 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 28 Feb 2024 | Sale | 2,303 | 16.1428 | 37,177 | D |
08 Nov 2023 16:22 | NVCR | NovoCure Ltd | SHAH PRITESH | Chief Growth Officer | 07 Nov 2023 | Sale | 382 | 12.65 | 4,832 | D |
05 Sep 2023 16:24 | NVCR | NovoCure Ltd | CORDOVA ASHLEY | Chief Financial Officer | 01 Sep 2023 | Sale | 883 | 21.8172 | 19,265 | D |
05 Sep 2023 16:24 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 01 Sep 2023 | Sale | 294 | 21.8172 | 6,414 | D |
05 Sep 2023 16:23 | NVCR | NovoCure Ltd | SHAH PRITESH | Chief Growth Officer | 01 Sep 2023 | Sale | 273 | 21.8172 | 5,956 | D |
04 Aug 2023 16:02 | NVCR | NovoCure Ltd | CORDOVA ASHLEY | Chief Financial Officer | 02 Aug 2023 | Sale | 1,144 | 30.2511 | 34,607 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)